Craig Collard is Chief Executive Officer of Heron Therapeutics, Inc. (HRTX). The company reported total compensation of $3,516,291 for fiscal year 2025.
| Salary | $689,431 |
|---|---|
| Bonus | $0 |
| Stock awards | $946,254 |
| Option awards | $1,352,917 |
| Non-equity incentive plan | $517,189 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $10,500 |
| Total | $3,516,291 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Heron Therapeutics, Inc. filed April 30, 2026, accession 0001193125-26-196306.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer | $689,431 | $0 | $946,254 | $1,352,917 | $517,189 | $0 | $10,500 | $3,516,291 |
| FY2024 | Chief Executive Officer | $515,000 | — | $129,557 | $473,779 | $296,125 | — | $10,350 | $1,424,811 |
| FY2023 | Chief Executive Officer | $492,986 | $0 | $547,273 | $9,257,049 | $326,957 | $0 | $151,553 | $10,775,818 |
Totals as disclosed in each year's own compensation disclosure for Heron Therapeutics, Inc..
| Peer-group chief executive median | $4,850,695 |
|---|---|
| Difference from that median | $-1,334,403 |
| Percentile within the disclosed peer group | 17th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Heron Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mark Hensley | Executive Vice President, Chief Operating Officer | $4,307,500 |
| Craig Collard this page | Chief Executive Officer | $3,516,291 |
| William Forbes | Executive Vice President, Chief Development Officer | $1,687,765 |
| Ira Duarte | Executive Vice President, Chief Financial Officer | $1,630,678 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Heron Therapeutics, Inc. compensation brief.
Craig Collard's compensation sits inside Heron Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.